论文部分内容阅读
1美国扩大Aromasin在乳腺癌治疗中的应用美国FDA已经批准将辉瑞制药公司的芳香酶抑制剂Aromasin(通用名:依西美坦片,exemestane tablet)用于连续5年接受激素辅助治疗的、患早期乳腺癌的绝经后妇女。这些妇女应是先接受2~3年他莫昔芬的治疗,并且雌激素受体呈阳性。英国已于美国?
1 United States to expand the application of Aromasin in breast cancer treatment The FDA has approved the Pfizer Aromatase Inhibitor Aromasin (common name: exemestane tablet) for 5 consecutive years of hormone-adjuvant therapy Postmenopausal women with early breast cancer. These women should first receive treatment for 2 to 3 years of tamoxifen and have estrogen receptor positive. Britain is in the United States?